key: cord-0050777-rflh9zkv
authors: Abdelmohsen, Mohsen Ahmed; Alkandari, Buthaina M.; Gupta, Vikash K.; ElBeheiry, Ahmed Adel
title: Diagnostic value of abdominal sonography in confirmed COVID-19 intensive care patients
date: 2020-09-29
journal: Egypt J Radiol Nucl Med
DOI: 10.1186/s43055-020-00317-9
sha: 9b58a3861042ce835f8a5842644787f9f7c6a627
doc_id: 50777
cord_uid: rflh9zkv

BACKGROUND: In December 2019, a large outbreak of a novel coronavirus infection occurred in Wuhan, China. The pneumonic disease caused by this virus is called coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). As case numbers have increased worldwide, gastro-intestinal symptoms like diarrhea, constipation, abdominal pain, and vomiting have been increased, these symptoms associated with positive laboratory results including abnormal liver function tests, renal function tests, and D-Dimer levels. Although there are multiple articles evaluated the imaging findings in HRCT of COVID-19 patients that helped in understanding the disease course and potential complications in the chest, yet there are—to our knowledge—limited data about the abdominal imaging findings of the course and potential abdominal complications of COVID-19 notably in the intensive care units (ICU). RESULTS: Forty-one sonographic examinations were done for 30 confirmed COVID-intensive care patients presented with abdominal symptoms. Of the 30 patients, 26 were males (86.66%), and 4 were females (13.3%), the average age of the patients was 57.7 years old. The most common sonographic observation was hepatomegaly (n, 23/41, 56%) and biliary system disease (n, 17/41, 41.4%); the imaging findings were correlated with the clinical and laboratory data. CT examination when indicated (in our study to assess hematomas for active extravasation and to assess bowel obstruction and its level). CONCLUSION: Abdominal sonographic imaging was often performed for inpatients with COVID-19. Hepatobiliary dysfunction as well as nephropathy was the most common imaging findings.

In December 2019, a large outbreak of a novel coronavirus infection occurred in Wuhan, China. The novel coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses [1] [2] [3] . The pneumonic disease caused by this virus is called coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO), on January 30, 2020, the WHO declared a global public health emergency against the outbreak of COVID-19. The WHO recognized the coronavirus disease 2019 (COVID-19) as a worldwide pandemic on March 11, 2020 [1, 2] .

The classical symptoms of COVID-19 are dry cough and fever and the diagnosis is confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) testing for SARS-Cov-2 nucleic acid. Early radiological studies focused on chest imaging with classical highresolution CT (HRCT) findings of peripheral patches of ground-glass densities with or without consolidations with bilateral basal predominance, organizing pneumonia pattern, crazy paving, mild bronchiectasis, and vascular engorgement may be encountered as well [4, 5] .

As case numbers have increased worldwide, gastrointestinal symptoms like diarrhea, constipation, abdominal pain, and vomiting have been increased; these symptoms are associated with positive laboratory results including abnormal liver function tests, renal function tests, and D-Dimer levels [6, 7] .

Although there are multiple articles evaluated the imaging findings in HRCT of COVID-19 patients that helped in understanding the disease course and potential complications in the chest, yet there are-to our knowledge-limited data about the abdominal imaging findings of the course and potential abdominal complications of COVID-19 [8] .

This retrospective study was conducted aiming to characterize the sonographic abdominal imaging findings in COVID-19 intensive care patients and to highlight the potential abdominal complications to help in understanding the pathogenesis of the disease in the abdomen.

This is a retrospective study analysis of 30 intensive care patients with confirmed COVID-19 infection and presented with abdominal signs and symptoms and/or abnormal visceral laboratory tests.

Each patient was subjected to the following: ultrasound machine) was used (to limit transport of the patients to the radiology department). MDCT: 3 CT examinations done for 3 patients, chest assessment was included in the study, the initial CT protocol was non-contrast scan and post-contrast scan in the venous phase, but this was tailored according to the clinical situation, scans in the arterial phase and delayed phase in the clinical context of abdominal pain and decrease hemoglobin level to investigate possible bleeders and these arterial and delayed scans were added in two patients with suspected spontaneous bleeding. Scans in the arterial and venous phases were added in one patient with suspected bowel obstruction and suspected ischemic bowel etiology. Reconstructions of the volume at 0.625 mm to 1.25 slice thickness, examinations were performed on Siemens Somatom Definition Edge 128 slice helical CT scanner.

Picture archiving and communication system viewer was used (GE PACS).

To decrease the subjective judgment and to reach objective assessment, the following definitions were respected: Gall bladder/bowel mural thickening (when measures more than 3 mm in diameter), gall bladder distention (when the gall bladder measures 4 cm in transverse diameter), acute cholecystitis (positive sonographic murphy's sign, thickened edematous wall pericholecystic collection, pericholecystic hyperemia).

Hepatomegaly (the liver right lobe measures more than 16 cm in midclavicular line)

Using portable machine to limit transport of the patients to the radiology department The transported patients to the department for CT examinations must wear a mask Droplet type precautions are used. All the attending medical staff should wear personal protective equipment (PPE) including: N95 mask, eye protective devices (googles/face shield), gowns, and gloves The machine is covered during the examination Proper cleaning following the examination was done 

In this retrospective study, 41 abdominal imaging studies were done for 30 intensive care confirmed COVID-19 patients presented with abdominal symptoms.

Of the 30 patients, 26 were males (86.6%, and 4 were females (13.33%), the age range from 91 to 21 years old, with mean age was 57.7 years old. The patients were distributed in Table 1 according to the age, the largest age group was (more than 50 to 60 years group ) included 8 patients (26.6%) ( Table 1) .

The most frequent indication for sonographic examinations was increase liver function tests especially serum bilirubin (n, 21/41; 51.2%) (Fig. 1) , followed by increase renal function tests (Fig. 2) (n, 6/41;14.6%) ( Table 2) .

Forty-one sonographic studies were done for 30 intensive care COVID-19 patients, 34 examination were positive for relevant findings (n, 34/41; 82.9%), and 7 sonographic studies were unremarkable (n, 7/41; 17.0%) ( Table 2) .

The most frequent sonographic finding was hepatomegaly (23/41, 56.09%), most of the cases showed increase liver function tests with bright echo pattern of the hepatic parenchyma, biliary system disease was the second most frequent observation (17/41; 41.47%) including gall bladder distention, biliary mud, wall thickening, and dilated common bile duct (Fig. 1) .

Nephropathy was the 3rd most common (n, 7/41; 17%); the most evident sonographic findings were increase renal parenchymal echogenicity bilaterally as well as parenchymal thinning (Fig. 2) (Table 3) .

Three patients were subjected to CT examinations, the indications for CT examination included to exclude active bleeding in two patients and to assess intestinal obstruction in one patient. Two patients subjected to sonographic studies followed by CT studies for more characterization and to exclude possible active extravasation (one patient with left rectus hematoma and another patient with rightsided retroperitoneal hematoma) (Fig. 3) , one patient with abdominal distention with limited sonographic assessment, and CT examination shows small bowel obstruction mostly of ischemic etiology (Fig. 4 ).

To our knowledge, there is a paucity of literature on sonographic abdominal imaging features of COVID-19 patients, by continuously increasing in number of the confirmed COVID-19 patients all over the world [9] , this study was done on both ICU and non-ICU patients with more frequent indications in their study like abdominal pain [9] . Up to date, the most acceptable pathogenesis of COVID-19 infection is that SARS-COV2 virus can gain access to the respiratory alveolar epithelial cells by binding to angiotensin-converting enzyme 2 (ACE2) receptors [10] , leading to cytokine-mediated immune response and inflammation, imaging findings, and disease course are further affected by severity of the cytokine-mediated inflammation (e.g., cytokine storm syndrome). Circulating cytokines can impact multiple other organ systems, causing secondary diseases and complications [11] .

ACE2 receptors are also found in the brain, arterial, and venous vascular endothelial cells, kidney, liver (hepatocytes and cholangiocytes), GIT, and gall bladder epithelial cells. This offers a chance for direct viral invasion of theses organs with variable clinical presentations and imaging spectrum [11, 12] .

In our study, male to female ratio was 6.5:1, while in Bhayana et al.'s study [9] , male to female ratio was 1.4:1, with similarity in increase male to female ratio in both studies.

Hepatomegaly was the most common findings in sonographic examinations with bright echo patterns reflecting diffuse hepatic parenchymal disease (n, 23/41; 56.1%) followed by biliary system disease (n, 17/41; a b c d e Ji et al. [14] demonstrated that COVID19 patients with high body mass index and non-alcoholic fatty liver disease (NAFLD) have a greater risk for both progressions in liver damage and COVID-19, in similarity to our study, these patients show increase liver function tests with hepatomegaly. Progression in liver damage related to NAFLD (and potentially other chronic liver disorders) will complicate COVID-19 presentation, clinical course, and the role of imaging, with the potential for hepatic failure, hepatic encephalopathy, and gastrointestinal bleeding [14] .

Sonographic findings of biliary disease were noted in 41.4% in our study sample, biliary system disease was noted in 54% in Bhayana et al.'s study [9] spectrum of gall bladder pathology was noted in our study including luminal mud, stone, mural thickening, signs of inflammation with edematous wall, mural hyperemia, and thin rim pericholecystic fluid could be noted, this spectrum of findings is similar to Bhayan et al.'s study with their population sample in their study including ICU and non-ICU patients. SARS-COV2 can bind to the gall bladder epithelial cells leading to mucosal inflammation and this can explain the sonographic observations [14] .

SARS-CoV-2 has a direct inflammatory effect on vascular endothelium [15] . Further, systemic coagulopathy is common in critically ill patients with COVID-19 [16, 17] . Tang et al. [16] found that next to an increased risk of thrombosis, patients seem to have an increased risk of bleeding as well, due to imbalances in platelet production and disruption, and disorders of the coagulation system. Coagulopathy sequel in our study was noted in four examinations (9.7%) including spontaneous hematomas noted in two examinations as well as vascular thrombotic sequel noted in two examinations. Major bleeding sequel to COVID-19 was noted in two patients only in Conti C et al.'s published study [17] .

Nephropathy was the 3rd most common sonographic observation (n, 7/41; 17%) in our study, associated increase in renal function tests was noted. Few studies focused mainly on renal histopathology in COVID-19 patients were published [18, 19] . Further dedicated imaging studies are needed for more clarification.

The authors recommend dealing with COVID-19 as a systemic disease possibly due to possible direct viral cytopathic effect on the ACE-2 receptors rich organs and/ or harmful systemic immune-mediated response to SARS-COV 2 infection.

The limitation of this study was that of a single-center retrospective study, which limits its generalizability. Pathologic correlation was not available for many patients with imaging abnormalities.

Dedicated sonographic abdominal imaging was often performed for COVID-19 intensive care patients with clinicolaboratory abnormal findings with subsequent improvement of the management plan. Hepatobiliary dysfunction, nephropathy as well as coagulopathy sequel in the abdomen were the most common imaging findings. COVID-19 should be considered as a systemic disease. 

Clinical characteristics of coronavirus disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist

Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea

High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: early experience from California

Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19)

Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19

Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Article -abdominal presentation of COVID-19

Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study

Endothelial cell infection and endotheliitis in COVID-19

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Bleeding in COVID-19 severe pneumonia: the other side of abnormal coagulation pattern?

COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Nill

Authors' contributions MA reported the cases and drafted the manuscript. BK collected the data. VKG performed part of the reporting and helped to draft the manuscript. AAE helped to collect the data. All authors have read and approved the final manuscript.

This study had no funding from any resource.

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Health as Asst. Undersecretary for planning and quality (1520/2020). All study procedures were carried out in accordance with the Declaration of Helsinki regarding research involving human subjects. Consent to participate was waived (retrospective study).

Not applicable

The authors declare that they have no competing interests.Author details 1